Casimersen (SRP-4045; Amondys 45) is an antisense oligonucleotide medication approved in 2021 for use in the treatment of Duchenne muscular dystrophy (DMD) in people who have a confirmed mutation of the dystrophin gene that is amenable to exon 45 skipping.

纯度：≥98%

CAS：1422958-19-7